Malonate produces striatal lesions by indirect NMDA receptor activation

Brain Res. 1994 May 30;647(1):161-6. doi: 10.1016/0006-8993(94)91412-5.

Abstract

We previously showed that local striatal injections of malonate produce age-dependent excitotoxic lesions. In the present study volumetric analysis confirmed that malonate produces age-dependent striatal lesions. Pretreatment with the non-competitive and competitive NMDA receptor antagonists, MK-801 and LY274614, and with lamotrigine resulted in significant protection in 4-month-old animals. In vivo magnetic resonance imaging of lesion area showed a significant correlation of increasing lesion size and lactate production in rats ranging from 1 to 12 months of age. Histological evaluation showed NADPH-diaphorase neurons were spared. The results provide further evidence that a subtle impairment of energy metabolism may play a role in neurodegenerative diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Corpus Striatum / pathology
  • Dizocilpine Maleate / pharmacology
  • Isoquinolines / pharmacology
  • Magnetic Resonance Imaging
  • Male
  • Malonates / pharmacology*
  • Oxidation-Reduction / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / drug effects*
  • Receptors, N-Methyl-D-Aspartate / metabolism

Substances

  • Isoquinolines
  • Malonates
  • Receptors, N-Methyl-D-Aspartate
  • LY 274614
  • Dizocilpine Maleate
  • malonic acid